CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemiareperfusion injury in mouse lung transplantation

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 5, 2012, Pages 1166-1173

  Jungraithmayr, Wolfgang ^a   De Meester, Ingrid ^b   Matheeussen, Veerle ^b   Baerts, Lesley ^b   Arni, Stephan ^a   Weder, Walter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

CD26 DPP 4; CXCR4; Ischaemia reperfusion injury; Orthotopic mouse lung transplantation; Progenitor cells; SDF 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; DIPEPTIDYL PEPTIDASE IV; FLT3 LIGAND; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; VILDAGLIPTIN; ADAMANTANE; CD34 ANTIGEN; CXCL12 PROTEIN, MOUSE; CXCR4 PROTEIN, MOUSE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DPP4 PROTEIN, MOUSE; DRUG DERIVATIVE; NITRILE; PYRROLIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL HOMING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CONVALESCENCE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; LUNG; LUNG EDEMA; LUNG HOMOGENATE; LUNG TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REPERFUSION INJURY; SPLEEN; STEM CELL; ANIMAL; C57BL MOUSE; DRUG EFFECT; DRUG SCREENING; HEMATOPOIETIC STEM CELL; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADAMANTANE; ANIMALS; ANTIGENS, CD34; CHEMOKINE CXCL12; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DRUG EVALUATION, PRECLINICAL; HEMATOPOIETIC STEM CELLS; INJECTIONS, SUBCUTANEOUS; LUNG; LUNG TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; NITRILES; PYRROLIDINES; RECEPTORS, CXCR4; REPERFUSION INJURY;

EID: 84863823133     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezr180     Document Type: Article

References (25)

1. De Meester I, Korom S, Van Damme J, Scharpe S. CD26, let it cut or cut it down. Immunol Today 1999;20:367-75.
2. Matheeussen V, Baerts L, De Meyer G, De Keulenaer G, Van der Veken PAugustyns K et al. Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries. Biol Chem 2011;392:189-198.
3. Huhn J, Ehrlich S, Fleischer B, von Bonin A. Molecular analysis of CD26-mediated signal transduction in T cells. Immunol Lett 2000;72: 127-132.
4. Durinx C, Lambeir AM, Bosmans E, Falmagne JB, Berghmans R, Haemers A et al. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur J Biochem 2000;267:5608-5613.
5. Zhai W, Jungraithmayr W, De Meester I, Inci I, Augustyns K, Arni S et al. Primary graft dysfunction in lung transplantation: the role of CD26/ dipeptidylpeptidase IV and vasoactive intestinal peptide. Transplantation 2009;87:1140-1146.
6. Zhai W, Cardell M, De Meester I, Augustyns K, Hillinger S, Inci I et al. Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/ reperfusion injury after extended ischemia. J Heart Lung Transplant 2007;26:174-180.
7. Jungraithmayr W, De Meester I, Matheeussen V, Inci I, Augustyns K, Scharpe S et al. Inhibition of CD26/DPP IV attenuates ischemia/reperfusion injury in orthotopic mouse lung transplants: the pivotal role of vasoactive intestinal peptide. Peptides 2010;31:585-591.
8. Campbell TB, Broxmeyer HE. CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation. Front Biosci 2008;13: 1795-1805.
9. Lapidot T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice: the role of SDF-1/CXCR4 interactions. Ann NY Acad Sci 2001;938:83-95.
10. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003;362: 697-703.
11. Ji JF, He BP, Dheen ST, Tay SS. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 2004;22:415-427.
12. Kollet O, Shivtiel S, Chen YQ, Suriawinata J, Thung SN, Dabeva MD et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003;112:160-169.
13. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004;114:438-446.
14. Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda A et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 2003;198:1391-1402.
15. Kanki S, Segers VF, Wu W, Kakkar R, Gannon J, Sys SU et al. Stromal cellderived factor-1 retention and cardioprotection for ischemic myocardium. Circ Heart Fail 2011;4:509-518.
16. Zaruba MM, Theiss HD, Vallaster M, Mehl U, Brunner S, David R et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 2009;4:313-323.
17. Marguet D, Baggio L, Kobayashi T, Bernard AM, Pierres M, Nielsen PF et al. Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci USA 2000;97:6874-6879.
18. Jungraithmayr WM, Korom S, Hillinger S, Weder W. A mouse model of orthotopic, single-lung transplantation. J Thorac Cardiovasc Surg 2009; 137:486-491.
19. Scharpe S, De Meester I, Vanhoof G, Hendriks D, van Sande M, Van Camp K et al. Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamine. Clin Chem 1988;34:2299-2301.
20. Korom S, De Meester I, Stadlbauer TH, Chandraker A, Schaub M, Sayegh MH et al. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation 1997;63: 1495-1500.
21. Santiago B, Calonge E, Del Rey MJ, Gutierrez-Canas I, Izquierdo E, Usategui A et al. CXCL12 gene expression is upregulated by hypoxia and growth arrest but not by inflammatory cytokines in rheumatoid synovial fibroblasts. Cytokine 2011;53:184-190.
22. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10: 858-864.
23. Farha S, Asosingh K, Xu W, Sharp J, George D, Comhair S et al. Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities. Blood 2011;117:3485-3493.
24. Xu J, Torres E, Mora AL, Shim H, Ramirez A, Neujahr D et al. Attenuation of obliterative bronchiolitis by a CXCR4 antagonist in the murine heterotopic tracheal transplant model. J Heart Lung Transplant 2008;27: 1302-1310.
25. Zhao G, al-Mehdi AB, Fisher AB. Anoxia-reoxygenation versus ischemia in isolated rat lungs. Am J Physiol 1997;273:L1112-L1117.